
Clinigene International Limited
About Clinigene International Limited
Data last updated:
Clinigene International Limited was a public limited company based in Bangalore, Karnataka, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 04 August 2000.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U85195KA2000PLC027566.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Kiran Mazumdar Shaw and John Mccallum Marshall Shaw.
Its last annual general meeting (AGM) was held on 23 July 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office was at Clinigene House Tower I Semicon Park Phase – II Electronics City Hosur Road, Bangalore, Karnataka, India – 560100.
As per the financials filed for FY 2014, the company reported a revenue of ₹44.41 Cr. For the same year it recorded EBITDA of ₹11.03 Cr (EBITDA margin 24.8%).
The company was associated with 1 brand: Clinigene International. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending. The company has 1 deal on record (1 acquisition); the latest was in December 2005. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Premas Biotech Private Limited with revenue of ₹45.93 Cr.
Company details
CIN history
Clinigene International has one previous CIN (Corporate Identification Number): U85195KA2000PTC027566. The current CIN is U85195KA2000PLC027566, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195KA2000PLC027566 | Current |
| U85195KA2000PTC027566 | Previous |
Contact details
Clinigene International Limited's registered office is in Bangalore, Karnataka.
- Registered AddressClinigene House Tower I Semicon Park Phase – II Electronics City Hosur Road, Bangalore, Karnataka, India – 560100
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Clinigene International operates one associated brand: Clinigene International. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides end-to-end clinical drug discovery and development solutions to biopharmaceutical companies. | clinigeneintl.com |
Financials of Clinigene International Limited
FY 2014 filings availableClinigene International Limited reported revenue of ₹44.41 Cr for FY 2014.
Financial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹11.03 Cr |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | 24.8% |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Clinigene International Limited, buy the company report.
Board of directors of Clinigene International Limited
Clinigene International has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Mazumdar Shaw | Director | 04 Aug 2000 | 26 Years 3 Months | As last reported |
| John Mccallum Marshall Shaw Also directs: Biocon Research Limited | Director | 04 Aug 2000 | 26 Years 3 Months | As last reported |
| Chinappa Muckatira Bhemaiah | Director | 07 Mar 2013 | 13 Years 8 Months | As last reported |
| Ravi Rasendra Mazumdar Also directs: Glenloch Properties LLP, Biocon Limited | Director | 20 Mar 2007 | 19 Years 7 Months | As last reported |
Peer comparison
Clinigene International Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Premas Biotech Private Limited | ₹45.93 Cr (FY 2025) | 65.0% | Manesar, Haryana, India | |||
| Vivo Bio Tech Limited | ₹45.49 Cr (FY 2024) | -13.0% | Hyderabad, Telangana, India | |||
| Intox Private Limited | ₹45.44 Cr (FY 2025) | -20.0% | Mulshi, Maharashtra, India | |||
| Shubham Specialty Products (India) Private Limited | ₹45.42 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Raghava Life Sciences Private Limited | ₹45.14 Cr (FY 2025) | -26.0% | Hyderabad, Telangana, India | |||
| Clinigene International Limitedthis company | ₹44.41 Cr (FY 2014) | Bangalore, Karnataka, India | ||||
| Scitus Pharma Services Private Limited | ₹43.45 Cr (FY 2025) | 17.0% | Chennai, Tamil Nadu, India | |||
| Invitron Advanced Analytics Private Limited | ₹43.29 Cr (FY 2025) | 45.0% | Hyderabad, Telangana, India | |||
| Anthem Bio Pharma Private Limited | ₹43.09 Cr (FY 2024) | 22.0% | Bangalore, Karnataka, India | |||
| Energon Labs Private Limited | ₹42.42 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India | |||
| Enem Nostrum Remedies Private Limited | ₹42.33 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Clinigene International Limited, buy the company report.
Deals & funding
Clinigene International Limited has 1 deal on record (1 acquisition); the latest was in December 2005.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2005 | Acquisition | Undisclosed | Buyer: Premier Research Inc. Seller: Biocon Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Clinigene International Limited has 4 court cases on record: 2 filed by Clinigene International, 2 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
| District courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Arbitration matter | Filed against the company by individuals | Pending |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by individuals | Disposed |
| High Court of Karnataka | Appeal | Filed by the company against an individual | Disposed |
| High Court of Karnataka | Court case (COP) | Filed by the company against an individual | Disposed |
To see the full case history of Clinigene International Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clinigene International Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Clinigene International Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Clinigene International Limited has 6 board changes on record since 2000: 4 appointments and 2 cessations. The latest: Chinappa Muckatira Bhemaiah ceased to be Additional Director on 24 Jul 2013.
Frequently asked questions
Clinigene International has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Clinigene International was a public limited company based in Bangalore, Karnataka, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 04 August 2000 and is registered under CIN U85195KA2000PLC027566. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Clinigene International was incorporated on 04 August 2000. It is registered with the Registrar of Companies, Bangalore.
Clinigene International had 4 directors:
- Kiran Mazumdar Shaw - Director
- John Mccallum Marshall Shaw - Director
- Chinappa Muckatira Bhemaiah - Director
- Ravi Rasendra Mazumdar - Director
The CIN (Corporate Identification Number) of Clinigene International is U85195KA2000PLC027566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Clinigene International is at Clinigene House Tower I Semicon Park Phase – II Electronics City Hosur Road, Bangalore, Karnataka, India – 560100.
The latest financial statements of Clinigene International on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 23 July 2014. Year-wise statements from 2015 are in the company report.
Clinigene International operated in the pharma industry, in the pharma contract r and d segment.
Clinigene International has 1 deal on record (1 acquisition); the latest was in December 2005.
The peers of Clinigene International by revenue are Premas Biotech Private Limited, Vivo Bio Tech Limited, Intox Private Limited, Shubham Specialty Products (India) Private Limited, Raghava Life Sciences Private Limited and 5 more, all in the Pharma industry (Contract Research).
Clinigene International has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.

